Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
As of close of business last night, Cabaletta Bio Inc’s stock clocked out at $2.17, up 1.40% from its previous closing price of $2.14. In other words, the price has increased by $1.40 from its previous closing price. On the day, 1.39 million shares were traded. CABA stock price reached its highest trading level at $2.185 during the session, while it also had its lowest trading level at $2.09.
Ratios:
To gain a deeper understanding of CABA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.60 and its Current Ratio is at 3.60. In the meantime, Its Debt-to-Equity ratio is 0.18 whereas as Long-Term Debt/Eq ratio is at 0.03.
On December 20, 2024, Evercore ISI Downgraded its rating to In-line which previously was Outperform and also lowered its target price recommendation from $15 to $6.
Wells Fargo Downgraded its Overweight to Equal Weight on December 19, 2024, whereas the target price for the stock was revised from $12 to $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CABA now has a Market Capitalization of 208895488 and an Enterprise Value of 74744496.
Stock Price History:
The Beta on a monthly basis for CABA is 3.26, which has changed by 0.03132534 over the last 52 weeks, in comparison to a change of 0.1877265 over the same period for the S&P500. Over the past 52 weeks, CABA has reached a high of $3.67, while it has fallen to a 52-week low of $0.99. The 50-Day Moving Average of the stock is -9.62%, while the 200-Day Moving Average is calculated to be 13.14%.
Shares Statistics:
It appears that CABA traded 4.00M shares on average per day over the past three months and 1869810 shares per day over the past ten days. A total of 96.27M shares are outstanding, with a floating share count of 84.43M. Insiders hold about 12.29% of the company’s shares, while institutions hold 64.30% stake in the company. Shares short for CABA as of 1765756800 were 18948919 with a Short Ratio of 4.74, compared to 1763078400 on 16196450. Therefore, it implies a Short% of Shares Outstanding of 18948919 and a Short% of Float of 20.02.
Earnings Estimates
. The current rating of Cabaletta Bio Inc (CABA) reflects the combined expertise of 5.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.44, with high estimates of -$0.36 and low estimates of -$0.48.
Analysts are recommending an EPS of between -$1.49 and -$2.46 for the fiscal current year, implying an average EPS of -$2.1. EPS for the following year is -$1.68, with 5.0 analysts recommending between -$1.17 and -$1.91.
